Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FYCPX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,047
Award facts
- Contract value 100% obligated
- $14,047.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On September 17, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $14,047.38 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the company's role in delivering specialized pharmaceutical commodities across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare customers. The SPE2DX vehicle under which this award was issued represents a comprehensive global pharmaceutical support contract enabling the company to fulfill ongoing federal medical supply requirements with flexible delivery capabilities.
Quick answers
Who was awarded contract SPE2DB25FYCPX?
SPE2DB25FYCPX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FYCPX worth?
The government has obligated $14,047 on SPE2DB25FYCPX.
Is contract SPE2DB25FYCPX an order under another contract?
Yes. SPE2DB25FYCPX is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB25FYCPX competed?
The extent of competition for SPE2DB25FYCPX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award